Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Keqiang Zhao

Clinical trials sponsored by Keqiang Zhao, explained in plain language.

Not yet recruiting 1
Sort by
  • Can powerful cholesterol drugs remodel dangerous artery plaques?

    Disease control Not yet recruiting

    Researchers are testing whether adding a PCSK9 inhibitor to standard statin therapy can stabilize vulnerable plaques in the carotid artery, the main blood vessel to the brain. The trial enrolls 120 adults with carotid narrowing and high-risk plaque features. Participants receive …

    Phase 4 • Sponsor: Keqiang Zhao • Aim: Disease control

    Last updated Sep 17, 2026 00:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space